Literature DB >> 22335783

Challenging the role of adaptive immunity in neurotrauma: Rag1(-/-) mice lacking mature B and T cells do not show neuroprotection after closed head injury.

Sebastian Weckbach1, Miriam Neher, Justin T Losacco, Ashley L Bolden, Liudmila Kulik, Michael A Flierl, Scott E Bell, V Michael Holers, Philip F Stahel.   

Abstract

The role of adaptive immunity in contributing to post-traumatic neuroinflammation and neuropathology after head injury remains largely unexplored. The present study was designed to investigate the pathophysiological sequelae of closed head injury in Rag1(-/-) mice devoid of mature B and T lymphocytes. C57BL/6 wild-type and Rag1(-/-) mice were subjected to experimental closed head injury, using a standardized weight-drop device. Outcome parameters consisted of neurological scoring, quantification of blood-brain barrier (BBB) function, measurement of inflammatory markers and mediators of apoptosis in serum and brain tissue, and assessment of neuronal cell death, astrogliosis, and tissue destruction. There was no difference between wild-type and Rag1(-/-) mice with regard to injury severity and neurological impairment for up to 7 days after head injury. The extent of BBB dysfunction was in a similar range for both groups. Quantification of complement activation fragments in serum revealed significantly attenuated C3a levels in Rag1(-/-) mice compared to wild-type animals. In contrast, the levels of pro- and anti-inflammatory cytokines and pro-apoptotic and anti-apoptotic mediators remained in a similar range for both groups, and the histological analysis of brain sections did not reveal a difference in reactive astrogliosis, tissue destruction, and neuronal cell death in Rag1(-/-) compared to wild-type mice. These findings suggest that adaptive immunity is not of crucial importance for initiating and sustaining the inflammatory neuropathology after closed head injury. The attenuated extent of post-traumatic complement activation seen in Rag1(-/-) mice implies a cross-talk between innate and adaptive immune responses, which requires further investigation in future studies.

Entities:  

Mesh:

Year:  2012        PMID: 22335783      PMCID: PMC3325549          DOI: 10.1089/neu.2011.2169

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  72 in total

Review 1.  Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategies.

Authors:  David J Loane; Alan I Faden
Journal:  Trends Pharmacol Sci       Date:  2010-10-29       Impact factor: 14.819

2.  What is the blood-brain barrier (not)?

Authors:  Ingo Bechmann; Ian Galea; V Hugh Perry
Journal:  Trends Immunol       Date:  2006-11-30       Impact factor: 16.687

3.  Regulation of chemokines and chemokine receptors after experimental closed head injury.

Authors:  V I Otto; P F Stahel; M Rancan; K Kariya; E Shohami; I Yatsiv; H P Eugster; T Kossmann; O Trentz; M C Morganti-Kossmann
Journal:  Neuroreport       Date:  2001-07-03       Impact factor: 1.837

4.  Complement plays an important role in spinal cord injury and represents a therapeutic target for improving recovery following trauma.

Authors:  Fei Qiao; Carl Atkinson; Hongbin Song; Ravinder Pannu; Inderjit Singh; Stephen Tomlinson
Journal:  Am J Pathol       Date:  2006-09       Impact factor: 4.307

5.  Mice deficient in complement receptors 1 and 2 lack a tissue injury-inducing subset of the natural antibody repertoire.

Authors:  Sherry D Fleming; Terez Shea-Donohue; Joel M Guthridge; Liudmila Kulik; Thomas J Waldschmidt; Matthew G Gipson; George C Tsokos; V Michael Holers
Journal:  J Immunol       Date:  2002-08-15       Impact factor: 5.422

6.  Beta-amyloid peptide-induced blood-brain barrier disruption facilitates T-cell entry into the rat brain.

Authors:  Ibolya G Farkas; Andrea Czigner; Eszter Farkas; Endre Dobó; Katalin Soós; Botond Penke; Valéria Endrész; András Mihály
Journal:  Acta Histochem       Date:  2003       Impact factor: 2.479

Review 7.  Exogenous progesterone: a potential therapeutic candidate in CNS injury and neurodegeneration.

Authors:  Zhiying Hu; Yan Li; Marong Fang; Maria S M Wai; David T Yew
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

Review 8.  Lymphocyte development and function in T-cell receptor and RAG-1 mutant mice.

Authors:  P Mombaerts
Journal:  Int Rev Immunol       Date:  1995       Impact factor: 5.311

9.  Therapeutic vaccination for closed head injury.

Authors:  Jonathan Kipnis; Uri Nevo; David Panikashvili; Alexander Alexandrovich; Eti Yoles; Solange Akselrod; Esther Shohami; Michal Schwartz
Journal:  J Neurotrauma       Date:  2003-06       Impact factor: 5.269

10.  Fluids and barriers of the CNS establish immune privilege by confining immune surveillance to a two-walled castle moat surrounding the CNS castle.

Authors:  Britta Engelhardt; Caroline Coisne
Journal:  Fluids Barriers CNS       Date:  2011-01-18
View more
  19 in total

Review 1.  Bridge between neuroimmunity and traumatic brain injury.

Authors:  Matthew L Kelso; Howard E Gendelman
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

2.  Activation of Myeloid TLR4 Mediates T Lymphocyte Polarization after Traumatic Brain Injury.

Authors:  Molly Braun; Kumar Vaibhav; Nancy Saad; Sumbul Fatima; Darrell W Brann; John R Vender; Lei P Wang; Md Nasrul Hoda; Babak Baban; Krishnan M Dhandapani
Journal:  J Immunol       Date:  2017-03-24       Impact factor: 5.422

Review 3.  Neuroimmunology of Traumatic Brain Injury: Time for a Paradigm Shift.

Authors:  Yasir N Jassam; Saef Izzy; Michael Whalen; Dorian B McGavern; Joseph El Khoury
Journal:  Neuron       Date:  2017-09-13       Impact factor: 17.173

Review 4.  Blood-brain barrier dysfunction following traumatic brain injury.

Authors:  Himakarnika Alluri; Katie Wiggins-Dohlvik; Matthew L Davis; Jason H Huang; Binu Tharakan
Journal:  Metab Brain Dis       Date:  2015-01-28       Impact factor: 3.584

Review 5.  Inflammation and neuroprotection in traumatic brain injury.

Authors:  Kara N Corps; Theodore L Roth; Dorian B McGavern
Journal:  JAMA Neurol       Date:  2015-03       Impact factor: 18.302

6.  The role of the immune system during regeneration of the central nervous system.

Authors:  K Z Sabin; K Echeverri
Journal:  J Immunol Regen Med       Date:  2019-11-05

Review 7.  Inflammation in Traumatic Brain Injury.

Authors:  Teodor T Postolache; Abhishek Wadhawan; Adem Can; Christopher A Lowry; Margaret Woodbury; Hina Makkar; Andrew J Hoisington; Alison J Scott; Eileen Potocki; Michael E Benros; John W Stiller
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

Review 8.  Emerging Roles for the Immune System in Traumatic Brain Injury.

Authors:  Celia A McKee; John R Lukens
Journal:  Front Immunol       Date:  2016-12-05       Impact factor: 7.561

9.  Anti-inflammatory and immunomodulatory mechanisms of atorvastatin in a murine model of traumatic brain injury.

Authors:  Xin Xu; Weiwei Gao; Shiqi Cheng; Dongpei Yin; Fei Li; Yingang Wu; Dongdong Sun; Shuai Zhou; Dong Wang; Yongqiang Zhang; Rongcai Jiang; Jianning Zhang
Journal:  J Neuroinflammation       Date:  2017-08-23       Impact factor: 8.322

10.  Deficiency of complement receptors CR2/CR1 in Cr2⁻/⁻ mice reduces the extent of secondary brain damage after closed head injury.

Authors:  Miriam D Neher; Megan C Rich; Chesleigh N Keene; Sebastian Weckbach; Ashley L Bolden; Justin T Losacco; Jenée Patane; Michael A Flierl; Liudmila Kulik; V Michael Holers; Philip F Stahel
Journal:  J Neuroinflammation       Date:  2014-05-24       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.